Verda Bio Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$545K
- Investors
-
1
Verda Bio General Information
Description
Developer of cannabinoid medicines designed to offer product formulation and dosing of cannabinoid-based therapeutics.The company combines analytical chemistry, technology, and genomic data to control for the variability in cannabis strains and create cannabinoid-based therapeutics, enabling healthcare providers to have access to medications that selectively meet the needs of specific patient populations.
Contact Information
Website
basicjane.comCorporate Office
- 2608 2nd Avenue
- Suite 158
- Seattle, WA 98121
- United States
Corporate Office
- 2608 2nd Avenue
- Suite 158
- Seattle, WA 98121
- United States
Verda Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 28-Sep-2016 | $545K | Completed | Generating Revenue |
Verda Bio Comparisons
Industry
Financing
Details
Verda Bio Competitors (8)
One of Verda Bio’s 8 competitors is Hyasynth, a Venture Capital-Backed company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hyasynth | Venture Capital-Backed | Montreal, Canada | ||||
| Teewinot Life Sciences | Formerly VC-backed | Tampa, FL | ||||
| Cannabis Science | Corporate Backed or Acquired | Irvine, CA | ||||
| Revive Therapeutics | Corporation | Toronto, Canada | ||||
| Ovid Therapeutics | Formerly VC-backed | New York, NY |
Verda Bio Patents
Verda Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260165268-A1 | Methods of cannabaceae plant breeding | Pending | 08-Aug-2022 | ||
| WO-2024036102-A2 | Methods of cannabaceae plant breeding | Inactive | 08-Aug-2022 | ||
| WO-2024036102-A3 | Methods of cannabaceae plant breeding | Inactive | 08-Aug-2022 | ||
| US-20220330466-P1 | Cannabis plant named 'vb252x' | Pending | 08-Apr-2021 | A01H6/28 |
Verda Bio Signals
Verda Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Rose Ventures | Venture Capital | Minority |
Verda Bio FAQs
-
When was Verda Bio founded?
Verda Bio was founded in 2013.
-
Where is Verda Bio headquartered?
Verda Bio is headquartered in Seattle, WA.
-
What is the size of Verda Bio?
Verda Bio has 3 total employees.
-
What industry is Verda Bio in?
Verda Bio’s primary industry is Drug Discovery.
-
Is Verda Bio a private or public company?
Verda Bio is a Private company.
-
What is Verda Bio’s current revenue?
The current revenue for Verda Bio is .
-
How much funding has Verda Bio raised over time?
Verda Bio has raised $545K.
-
Who are Verda Bio’s investors?
Rose Ventures has invested in Verda Bio.
-
Who are Verda Bio’s competitors?
Hyasynth, Teewinot Life Sciences, Cannabis Science, Revive Therapeutics, and Ovid Therapeutics are some of the 8 competitors of Verda Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process